Table 1.
Prescribed drug prevalence by BNF main chapter and specific sections
BNF chapter | BNF subsections | BNF classification | Drug examples | Number | Drug prevalence/ 10 000† |
---|---|---|---|---|---|
2 Cardiovascular system | 9384 | 7289 | |||
2.9 | Antiplatelet drugs | Aspirin, clopidogrel, dipyridamole | 5044 | 3918 | |
2.8 | Anticoagulants | Warfarin | 669 | 520 | |
2.2 | Diuretics | Thiazide diuretics | 4912 | 3815 | |
2.4 | β-blockers | Bisoprolol | 4034 | 3133 | |
2.5 | ACE inhibitors or ARB | Ramipril, candesartan | 4250 | 3301 | |
2.6 | nitrates, calcium antagonists | GTN, amlodipine | 4984 | 3817 | |
2.12 | Lipid regulating drugs | Simvastatin | 4894 | 3801 | |
3 Respiratory system | 2861 | 2222 | |||
3.1 | Bronchodilators | Salbutamol | 2775 | 2155 | |
3.2 | Corticosteroids | Beclomethasone | 2140 | 1662 | |
3.6 | Oxygen | NA | 94 | 73 | |
4 Central nervous system drugs | 7478 | 5808 | |||
4.7.1 | Non-opioid analgesics | Paracetamol | 5395 | 4190 | |
4.7.2 | Opioid analgesics | Codeine, tramadol | 855 | 664 | |
4.1 | Hypnotics and anxiolytics | Diazepam | 1180 | 917 | |
4.3 | Selective serotonin reuptake inhibitors Tricyclic antidepressants |
Fluoxetine, citalopram, amitriptyline | 3241 | 2517 | |
6 Endocrine system | 2916 | 2265 | |||
6.1.1 | Insulin | Insulin, humalog | 632 | 491 | |
6.1.2 | Oral antidiabetic drugs | Metformin, gliclazide | 2334 | 1805 | |
10 Musculoskeletal and joint disease | 2143 | 1664 | |||
10.1.1 | Non-steroidal anti-inflammatory drugs | Ibuprofen, cyclooxygenase inhibitors | 2143 | 1664 |
†Population refers to those with one of six chronic conditions (n = 12 875), which included hypertension, diabetes, coronary heart disease, cerebrovascular disease, chronic obstructive pulmonary disease, osteoarthritis and depression; drug categories are based on the BNF classification.
ACE, angiotensin-converting-enzyme; ARB, angiotensin II receptor blockers; BNF, British National Formulary; GTN, glyceryl trinitrate; NA, not applicable.